On April 4, President Droupadi Murmu unveiled the nation’s first indigenous gene therapy for cancer at the prestigious Indian Institute of Technology, Bombay. The therapy, known as CAR-T cell therapy, is going to revolutionise cancer treatment not only in India but worldwide. It is not only effective but also affordable.
President Droupadi Murmu also added that this therapy will help humanity and initiate many new transformations. This milestone is a breakthrough for the nation, and for so long, people have been waiting for something like this. India will not limit itself to us alone but will also help people from all the nations.
CAR-T cell therapy stands as one of the most remarkable advancements in the field of medical science. It is already available in some developed nations, like the United States of America and Canada, but the therapy cost there is unbearable, and people usually fail to get this therapy, which is quite tragic. But now India will produce this therapy at an affordable price without seeing someone’s citizenship.
President Droupadi Murmu’s excitement can be seen during her speech when she announced that this CAR-T cell therapy will be the most affordable CAR-T cell therapy in the world, showcasing India’s commitment to inclusivity and progress.
CAR-T cell therapy made by Indians is a showcase of Indian dedication towards Atamnirbhar Bharat, and India will continue to serve the world by making more such revolutionary medicines and therapies.
CAR-T cell therapy developed through a collaborative effort between the Indian Institute of Technology, Bombay, Tata Memorial Hospital, and industry partner ImmunoACT, India’s first CAR-T cell therapy, epitomises the synergy between academia and industry, setting a commendable precedent for future collaborations.